BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2971078)

  • 1. High blood pressure is a major factor in progression of diabetic nephropathy.
    Parving HH; Hommel E
    J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA
    Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1990 Dec; 8(7):S187-91. PubMed ID: 2095388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy.
    Lithovius R; Harjutsalo V; Forsblom C; Saraheimo M; Groop PH;
    Diabetes Care; 2014; 37(3):709-17. PubMed ID: 24170765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy.
    Wang Y; Wang C; Zhang X; Gu HF; Wu L
    Curr Diabetes Rev; 2018; 14(2):149-161. PubMed ID: 28201968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.
    Parving HH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S19-24. PubMed ID: 1382160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
    Mogensen CE; Petersen MM; Hansen KW; Christensen CK
    J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hypertension, diabetes mellitus and the kidney.
    Christlieb AR; Krolewski AS; Warram JH
    Am J Cardiol; 1987 Dec; 60(17):61I-65I. PubMed ID: 3687807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate.
    Dragović T; Ajdinović B; Hrvacević R; Ilić V; Magić Z; Andelković Z; Kocev N
    Vojnosanit Pregl; 2010 Apr; 67(4):273-8. PubMed ID: 20465154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetes; 1993 May; 42(5):715-9. PubMed ID: 8482428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of treatment of arterial hypertension on renal function in patients with imminent and overt diabetic nephropathy].
    Czekalski S; Pynka S; Majkowska L; Andrysiak-Mamos E; Krzyzanowska-Swiniarska B
    Pol Arch Med Wewn; 1994; 92 Spec No():60-9. PubMed ID: 7731901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
    Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
    Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of blood pressure intervention on renal function in insulin-dependent diabetes.
    Mogensen CE
    Diabete Metab; 1989; 15(5 Pt 2):343-51. PubMed ID: 2612718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.